CCI15106
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CCI15106, covering 2019-09-27 to 2019-09-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug [Phase 1]